2021 annual financial data

Viridian Therapeutics 2021 Net margin

Viridian Therapeutics 2021 net margin with verified reported values.

Direct answer

Net margin was -2,680.16%.

Operating income was -79,728,000 USD and net income was -79,413,000 USD.
Operating cash flow was -54,581,000 USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2,963,000 USD
Operating income
-79,728,000 USD
Net income
-79,413,000 USD
Operating cash flow
-54,581,000 USD